Neurostimulation Devices Market - Top Companies and Manufacturers

  • Report ID: 4239
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Companies Dominating the Neurostimulation Devices Landscape

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Boston Scientific Corporation
    • Integer Holdings Corporation
    • Medtronic
    • Nevro Corp.
    • NeuroSigma, Inc.
    • NeuroPace, Inc.
    • Neuronetics
    • Synapse Biomedical Inc.
    • Soterix Medical, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Nevro Corp., a global medical device company, today announced that its Senza system has been successfully approved by the FDA for the treatment of chronic pain associated with painful diabetic neuropathy (PDN). With the approval, the company will immediately begin its commercial production in the United States.

  • NeuroSigma, Inc., a bioelectronic medical device company, today announced that the company received an equity investment of USD 5 million from KT Corporation, an international digital telecommunication company. With the investment, the company will support the commercialization and development of Monarch eTNS Systems and accelerate the business growth trajectory of NeuroSigma.

 


Author Credits:  Radhika Pawar


  • Report ID: 4239
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of neurostimulation devices is evaluated at USD 12.42 billion.

The neurostimulation devices market size was valued at USD 11.32 billion in 2024 and is poised to exceed USD 50.56 billion by the end of 2037, registering over 12.1% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of chronic pain and increasing neurological disorders will drive the market growth.

North America industry is expected to account for majority revenue share by 2037, driven by increasing prevalence of neurological disorders and the increasing level of the geriatric population in the region.

The major players in the market include Abbott Laboratories, Boston Scientific Corporation, Integer Holdings Corporation, Medtronic, Nevro Corp., NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Synapse Biomedical Inc., Soterix Medical, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample